Benzinga | Nov 9, 2020 07:30AM EST

Cogent Biosciences Q3 EPS $(5.07) Down From $(1.56) YoY, Sales $312.00K Down From $1.02M YoY

Cogent Biosciences (NASDAQ:COGT) reported quarterly losses of $(5.07) per share. This is a 225 percent decrease over losses of $(1.56) per share from the same period last year. The company reported $312.00 thousand in sales this quarter. This is a 69.41 percent decrease over sales of $1.02 million the same period last year.